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he neural cell adhesion molecule (NCAM) has been
 
reported to stimulate neuritogenesis either via non-
receptor tyrosine kinases or ﬁbroblast growth factor
(FGF) receptor. Here we show that lipid raft association of
NCAM is crucial for activation of the nonreceptor tyrosine
kinase pathway and induction of neurite outgrowth. Trans-
fection of hippocampal neurons of NCAM-deﬁcient mice
revealed that of the three major NCAM isoforms only
NCAM140 can act as a homophilic receptor that induces
T
 
neurite outgrowth. Disruption of NCAM140 raft association
either by mutation of NCAM140 palmitoylation sites or by
lipid raft destruction attenuates activation of the tyrosine
 
focal adhesion kinase and extracellular signal–regulated
 
kinase 1/2, completely blocking neurite outgrowth. Likewise,
NCAM-triggered neurite outgrowth is also completely
blocked by a speciﬁc FGF receptor inhibitor, indicating
that cosignaling via raft-associated kinases and FGF receptor
is essential for neuritogenesis.
 
Introduction
 
Neurite outgrowth is a major event in neural development
being mediated by several members of the immunoglobulin
superfamily of cell adhesion molecules, among them the
 
neural cell adhesion molecule (NCAM).* NCAM is expressed
on the surface of almost all neural cells throughout the cen-
tral and peripheral nervous system. It plays a pivotal role in
early brain development, synaptic plasticity, and memory
consolidation (Schachner, 1997; Ronn et al., 1998) and pro-
motes neurite outgrowth upon homophilic or heterophilic
engagement with other molecules on adjacent cell surfaces
and in the extracellular matrix (for review see Crossin and
Krushel, 2000). This implicates NCAM both as a ligand and
signal transducing receptor. Of the three major isoforms of
NCAM (NCAM180, NCAM140, and NCAM120, named
according to their apparent molecular masses), all have been
found to serve as neuritogenic ligands (Doherty et al., 1989,
1990) due to their identical extracellular domains.
 
First attempts to elucidate the molecular events underly-
ing NCAM-mediated neuritogenesis have attributed a
 
fundamental role to the fibroblast growth factor (FGF)
receptor (Williams et al., 1995). Overexpression of a trun-
cated FGF receptor-1 with a deleted kinase domain inhib-
ited neurite outgrowth of PC12 cells when cultured on
NCAM-presenting fibroblasts (Saffell et al., 1997). The
ability of NCAM to promote neurite outgrowth was sug-
gested therefore to depend solely on the interaction between
the extracellular domains of NCAM and the FGF receptor.
According to this concept, the interaction of NCAM with
the FGF receptor activates the receptor tyrosine kinase with
 
subsequent activation of PLC
 
 
 
. As a final consequence,
 
Ca
 
2
 
 
 
 influx into the neurons results in neurite growth.
The view that the FGF receptor may not be the only
mediator of NCAM-dependent signal transduction was in-
dicated by data showing that NCAM-dependent neurite
outgrowth is impaired in cultured neurons from mice defi-
cient in the nonreceptor tyrosine kinase fyn (Beggs et al.,
1994). Moreover, immunoprecipitation studies revealed an
association of NCAM140 but not NCAM180 with fyn
(Beggs et al., 1997). According to this model, NCAM
clustering at the cell surface induces fyn phosphorylation
with further recruitment of the focal adhesion kinase (FAK)
to the NCAM–fyn complex. Activation of downstream
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kinases by this complex is then thought to be the initial step
in NCAM-mediated neurite outgrowth.
Although the two signaling mechanisms would appear
distinct at first sight, it is conceivable that both pathways
could be operant in cells expressing NCAM isoforms as re-
ceptors for neurite outgrowth. The possibility also needs to
be considered that activation of these signaling pathways
could depend on the particular localization of the individual
NCAM isoforms in different membrane subcompartments
at the cell surface. Based on the observation that the intracel-
lular domains of NCAM140 can be palmitoylated at four
cysteine residues adjacent to the transmembrane domain
(Little et al., 1998), we asked whether localization to choles-
terol-rich membrane microdomains, the so-called lipid rafts,
or detergent-resistant microdomains could play a major role
in signal transduction mediated by NCAM. These lipid rafts
reveal high concentrations of cholesterol and sphingogly-
colipids and thereby a higher resistance toward nonionic de-
tergents such as Triton X-100 than other membrane com-
partments. Several studies have illuminated the involvement
of lipid rafts in signaling of hematopoietic cells (Brown and
London, 1998), and there is growing evidence that transi-
tion of cellular receptors into rafts can enhance downstream
signaling (Cinek and Horejsi, 1992; Tansey et al., 2000).
Since these microdomains are enriched in potent effectors of
signal transduction (e.g., src family kinases and growth-asso-
ciated protein [GAP]-43) (Simons and Ikonen, 1997), the
accumulation of NCAM receptors in these microdomains
might regulate downstream signaling in a particular manner.
Therefore, we asked whether raft localization of particular
NCAM isoforms was essential for downstream signaling
leading to neurite outgrowth. In parallel, we intended to elu-
cidate the relationship between NCAM-mediated signaling
via lipid rafts and signal transduction via the FGF receptor
that has been demonstrated to be present outside of rafts at
the cell surface (Davy et al., 2000).
 
Results
 
All NCAM isoforms are present 
in lipid raft microdomains
 
Since NCAM140 and NCAM180 share the same palmitoy-
lation sites in sequences located intracellularly close to the
plasma membrane, we asked whether both isoforms can be
present in lipid rafts. We used brain homogenates and two
cell lines, neuroblastoma cells expressing the three major iso-
forms of NCAM and NCAM-negative CHO cells that were
used for transfection with the NCAM isoforms.
Insolubility in cold nonionic detergents and flotation on
 
sucrose density gradients are the well-established criteria
for identification of lipid raft-associated proteins (Hooper,
1997). Using flotation gradients, we determined NCAM
isoform localization in the Triton X-100–insoluble low den-
sity membrane fractions (raft associated) and in the insolu-
ble high density fraction (probably cytoskeleton associated).
In the homogenate of forebrains of 2-d-old mice, all three
main NCAM isoforms could be detected in the top fractions
of the flotation gradient (Fig. 1 A, top, lanes 3 and 4), con-
firming an association of the NCAM isoforms with low den-
sity lipids in raft microdomains. A large fraction of NCAM
molecules in the raft fractions appeared to be polysialylated,
since a broad band could be detected extending from 180
kD to higher apparent molecular weights. The nonreceptor
tyrosine kinase fyn (Fig. 1 A, middle), which has been de-
scribed as raft associated (van’t Hof and Resh, 1997) and the
FAK (Fig. 1 A, bottom) were also found in the low density
fractions of the gradient, thus codistributing NCAM with a
potential signaling effector in the lipid raft fraction.
Also in neuroblastoma cells, all isoforms were present in
the top fractions of the flotation gradient, confirming the as-
sociation with lipids rafts (Fig. 1 B, lanes 2–4). The nonre-
ceptor tyrosine kinase fyn also codistributed with NCAM in
the upper fractions. However, whereas NCAM120 was
mainly raft associated (Kramer et al., 1999) high amounts of
NCAM140 and NCAM180 remained in the Triton X-100–
insoluble bottom fractions (Fig. 1 B, lanes 8 and 9) of the
Figure 1. NCAM is present in detergent-resistant membrane 
fractions separation of Triton X-100–insoluble proteins by sucrose 
gradient fractionation. (A) Immunoblot analysis of homogenates of 
forebrain. NCAM isoforms are present in the Triton X-100–insoluble 
low density fractions (lanes 3 and 4) representing the lipid raft 
fraction and in the Triton X-100–insoluble high density fraction 
(lane 6), possibly containing cytoskeleton-associated proteins (top). 
The raft-associated nonreceptor tyrosine kinase fyn (middle) and the 
focal adhesion kinase FAK (bottom) colocalize with NCAM in the 
low density lipid raft fractions. (B) Immunoblot analysis of neuro-
blastoma cells. NCAM140 and NCAM180 are present in the Triton 
X-100–insoluble low density fractions (lanes 2–4) representing the 
lipid raft fraction and in the Triton X-100 insoluble high density 
fraction (lane 9). In contrast, the GPI-linked NCAM120 is mainly 
present in the raft fractions (lane 2–4) with only small amounts in 
the high density Triton X-100–insoluble fractions (lane 9). The 
raft-associated nonreceptor tyrosine kinase fyn is also exclusively 
present in the low density fraction. IB, immunoblot for the 
molecules indicated. 
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flotation gradient, probably associated with cytoskeletal pro-
teins (Montixi et al., 1998).
Additionally, fluorescence signals indicating NCAM anti-
body localization partially overlapped with the staining for
the lipid raft markers ganglioside GM1 and phosphati-
dylinositolbisphosphate (PIP
 
2
 
) (Laux et al., 2000) in cul-
tured hippocampal neurons (Fig. S1 available at http://
www.jcb.org/cgi/content/full/jcb.200109059/DC1).
 
Mutation of the palmitoylation sites abolishes the 
presence of NCAM140 in rafts
 
To investigate the importance of intracellular palmitoylation
for the association of NCAM with lipid rafts, an NCAM140
mutant was constructed which lacks its four palmitoylation
sites by replacing the four intracellular cysteines with serines
(Fig. 2 A, NCAM140
 
 
 
). We then investigated whether
NCAM localizes to rafts in transfected CHO cells. Analysis of
the subcellular distribution of NCAM140 in transfected CHO
cells revealed an association of NCAM140 with lipid rafts (Fig.
2 B, left, lanes 2 and 3). In contrast, NCAM140
 
 
 
 was drasti-
cally reduced in lipid rafts when compared with NCAM140
(Fig. 2 B, right, lanes 2 and 3), indicating that palmitoylation is
a major determinant in the localization of NCAM140 to lipid
rafts. Mutation of NCAM140 palmitoylation sites did not sig-
nificantly influenced the overall expression of the protein (Fig.
2 C) or its surface expression (Fig. 8 B). The amount of
NCAM140
 
 
 
 was also reduced in the bottom fraction of the
sucrose gradient, indicating an overall reduced Triton X-100
insolubility (Fig. 2 B, right, lane 6) of the protein.
 
To investigate whether NCAM140
 
 
 
 would show simi-
lar features in neurons as in CHO cells, we transfected
cultured hippocampal neurons of NCAM-deficient
(NCAM
 
 
 
/
 
 
 
) mice with NCAM140 and NCAM140
 
 
 
 and
monitored the raft localization of the two proteins immu-
nocytochemically by treating the cells with cold Triton
X-100 followed by immunostaining for NCAM and the
raft markers GM1 ganglioside and PIP
 
2
 
 (Fig. 3 A). In
cold Triton X-100, nonraft proteins become solubilized,
whereas raft-associated and cell cytoskeleton–associated
proteins remain in the cell membrane (Ledesma et al.,
1998). After extraction with cold Triton X-100, multiple
clusters of NCAM140 and NCAM140
 
 
 
 were still detected
along neurites. Some of NCAM140 clusters colocalized
with GM1 and PIP
 
2
 
 immunoreactivity (Fig. 3 A), indicat-
ing that NCAM140 is present in lipid rafts. In contrast,
NCAM140
 
 
 
 clusters did not significantly colocalize with
GM1 and PIP
 
2
 
 (Fig. 3 A), supporting the view that palmi-
toylation is essential for NCAM140 localization to lipid
rafts. Some NCAM140 and NCAM140
 
 
 
 clusters not
colocalizing with GM1 and PIP
 
2
 
 remained insoluble in
cold Triton X-100, probably due to cytoskeletal associa-
tion. Finally, we quantified differences in raft localization
of NCAM140 and NCAM140
 
 
 
 by measuring the in-
tensity of GM1 immunofluorescence within clusters of
NCAM staining. Measurement of fluorescence signals re-
vealed that raft localization of NCAM140
 
 
 
 was reduced
by 
 
 
 
80% compared with NCAM140 in hippocampal
neurons (Fig. 3 B).
Figure 2. Mutation of NCAM140 palmitoylation 
sites abolishes NCAM140 raft association. (A) Schematic 
diagram of the structure of NCAM140 and NCAM140 . 
The plasma membrane is indicated by the pair of 
vertical lines. The semicircles represent the five Ig-like 
domains. The two fibronectin type III–like domains 
are shown as black boxes. The expanded segment 
shows the NH2-terminal sequence of the cytoplasmic 
domain and the four cysteines that were mutated to 
serines in the NCAM140  construct to remove all 
sites for palmitoylation. (B) Immunoblot analysis of 
sucrose gradient fractions of NCAM140- (left) and 
NCAM140 - (right) transfected CHO cells. NCAM140 
is present both in the Triton X-100–insoluble low 
density raft fractions (lanes 2 and 3) and high density 
fraction (lane 6). To estimate the percentage of raft-
associated NCAM140 versus total NCAM140, we 
normalized the densitometrically determined immuno-
blot intensity of the NCAM140 bands in the total cell 
lysate (C) and in the raft fractions (B, left, lanes 2 and 
3) to the total protein subjected to SDS-PAGE. Relating 
the amount of NCAM140 present in lipid rafts to the 
total amount of NCAM140 revealed that  2% of the 
total NCAM140 protein is present in the lipid raft 
fractions. Analysis of the sucrose gradient fractions of 
NCAM140 -transfected cells shows a drastically 
reduced amount of NCAM in the low density fractions 
(lanes 2 and 3) and the high density bottom fraction (lane 6), indicating that palmitoylation is essential for NCAM140 to be present in lipid 
rafts and in the cytoskeletal-associated fraction. The blots of the NCAM140 and NCAM140  gradient fractions were reprobed with fyn anti-
bodies to confirm both equal protein loading and equal isolation of the lipid raft fractions. (C) Immunoblot analysis of the total cell lysate of 
NCAM140- and NCAM140 -transfected CHO cells using polyclonal NCAM antibodies. Comparison of expression levels in CHO cells 
transfected with both constructs indicate that mutation of the four cysteines did not significantly alter protein expression. (D) Immunoblot 
analysis of the Triton X-100–soluble (S) and the Triton X-100–insoluble fraction (IS) of a CHO cell lysate using a FGF receptor-1 antibody 
revealed that the FGF receptor (FGFR-1) is only present in the Triton X-100–soluble fraction. IB, immunoblot for the molecules indicated. 
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As a next step, we addressed the question of the physiolog-
ical relevance of the lipid raft localization of NCAM iso-
forms for activation of the fyn-FAK pathway and focused on
the functional connection to the FGF receptor activation,
which has been shown by us (Fig. 2 D) and others to be ab-
 
sent in the Triton X-100–insoluble fraction (Davy et al.,
2000).
 
NCAM120 activates extracellular signal–regulated 
kinase 1/2 independently of the FGF receptor, whereas 
NCAM180 signaling is FGF receptor dependent
 
To determine the functional importance of NCAM localiza-
tion to lipid rafts, we first investigated whether the three iso-
forms could activate the extracellular signal–regulated kinase
(ERK)1/2 pathway in an FGF receptor–dependent manner
and then asked how disruption of the lipid raft association
may alter NCAM-mediated signaling. As described earlier,
we used polyclonal NCAM antibodies to trigger NCAM-
dependent signaling (Schuch et al., 1989; Schmid et al., 1999)
and investigated ERK1/2 phosphorylation by immunoblot
analysis using a phosphorylation state–specific antibody. To
investigate a possible raft-dependent signaling of NCAM
that is independent of the previously described FGF recep-
tor–dependent signaling (Saffell et al., 1997; Kolkova et al.,
2000a), endogenously expressed FGF receptors need to be
blocked completely. The FGF receptor inhibitor PD173074
was used in this study, since it specifically inhibits signaling
of the FGF receptor, leaving other tyrosine kinases unaf-
fected (Fig. S2 available at http://www.jcb.org/cgi/content/
full/jcb.200109059/DC1) (Skaper et al., 2000).
Stimulation of neuroblastoma cells with polyclonal NCAM
antibodies showed an up-regulation of ERK1/2 phos-
phorylation 10 min after addition of antibodies (Fig. 4) as
has also been reported in previous studies (Schmid et al.,
1999). This activation was not attenuated by the FGF recep-
tor inhibitor, indicating that stimulation of at least one of
the NCAM isoforms expressed by neuroblastoma cells can
activate ERK1/2 in an FGF-independent manner. Since
neuroblastoma cells expressed all three major NCAM iso-
forms (Fig. 1 B), we studied whether NCAM signaling
could be reconstituted with respect to the ERK1/2 activa-
tion in CHO cells transfected with one of the individual
NCAM isoforms. For control, exposure of untransfected
CHO cells to polyclonal NCAM antibodies did not result in
mitogen-activated protein (MAP) kinase phosphorylation
Figure 3. NCAM140  is excluded from lipid rafts in cultured 
hippocampal neurons. (A) Confocal images of immunofluorescence 
staining of Triton X-100–treated hippocampal neurons from NCAM
 /  
mice transfected with either NCAM140 or NCAM140 . Cells were 
stained for NCAM and GM1 or PIP2. Arrows show clusters of NCAM 
(red) colocalizing with GM1 or PIP2 (green). In NCAM140-transfected 
NCAM
 /  neurons, multiple clusters of NCAM coincided with GM1 
or PIP2 staining, whereas in NCAM140 -transfected NCAM
 /  
neurons the overlap of NCAM staining with GM1 or PIP2 staining 
is strongly reduced. Although not raft associated, a fraction of 
NCAM140  remains Triton X-100 insoluble, possibly due to 
interaction with the cytoskeleton. Bars, 10  m. (B) Bar graph shows 
quantification of fluorescence signal of GM1 staining within clusters 
of NCAM staining. Intensity of GM1 staining within clusters of 
NCAM140  is reduced significantly compared with NCAM140 
clusters (*p   0.01).
Figure 4. The FGF receptor inhibitor does not impair NCAM-
mediated ERK1/2 activation. Neuroblastoma cells were assayed 
for ERK1/2 kinase activation using a phosphorylation state-specific 
ERK1/2 antibody by immunoblot analysis. Polyclonal NCAM anti-
bodies induce phosphorylation of ERK1/2 10 min after antibody 
application. PD173074 did not impair NCAM-mediated ERK1/2 
phosphorylation, indicating a FGF receptor–independent signaling 
of NCAM in neuroblastoma cells. Control experiments show that 
neither carrier (DMSO) nor normal rabbit IgG activate ERK1/2. 
IB, immunoblot for the molecules indicated. 
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(Fig. S2 available at http://www.jcb.org/cgi/content/full/
jcb.200109059/DC1). In NCAM120-, NCAM140-, and
NCAM180-transfected CHO cells, ERK1/2 was phos-
phorylated 20 min after application of the NCAM antibod-
ies as seen in neuroblastoma cells, indicating that all NCAM
isoforms are capable to activate the MAP kinase in CHO
cells, although possibly with different potency. We then
compared the FGF receptor dependency of the individual
NCAM isoforms with regard to ERK1/2 activation. Anti-
body stimulation of NCAM120-transfected CHO cells re-
sulted in ERK1/2 phosphorylation that was not blocked by
the FGF receptor inhibitor, indicating an FGF receptor–
independent signaling of this isoform (Fig. 5 A). Compari-
son of NCAM180- and NCAM140-mediated signaling
Figure 5. In transfected CHO cells, 
NCAM120 activates ERK1/2 in a FGF 
receptor–independent manner, whereas 
NCAM180-mediated ERK1/2 activation 
is FGF receptor dependent. CHO cells 
were transfected with NCAM120 or 
NCAM180 and stimulated with polyclonal 
NCAM antibodies. (A) Immunoblot of 
NCAM120-transfected CHO cell lysates 
analyzed for phosphorylated ERK1/2 
(top). Bar graph shows ERK1/2 phosphor-
ylation by densitometric analysis of 
immunoblots (bottom). Stimulation of 
NCAM120-transfected CHO cells result 
in phosphorylation of ERK1/2, which is 
independent of the presence of 
PD173074, indicating that activation 
of ERK1/2 by NCAM120 is FGF receptor 
independent. (B) Immunoblot of 
NCAM180-transfected CHO cell lysates 
analyzed for phosphorylated ERK1/2 
(top). Bar graph shows ERK1/2 phos-
phorylation by densitometric analysis 
of immunoblots (bottom). NCAM180-
mediated ERK1/2 activation is attenuated 
by the FGF receptor inhibitor, showing FGF receptor dependency of NCAM180 signaling with respect to ERK1/2 activation. The bars show 
means and SEM of four independent experiments. Asterisks denote statistical significance (paired t test) of attenuation of ERK1/2 phosphory-
lation due to treatment with the FGF receptor inhibitor compared with NCAM-mediated ERK1/2 activation in transfected CHO cells, which 
were not treated with PD173074 (**p   0.005; ***p   0.0005). IB, immunoblot for the molecules indicated.
Figure 6. Deletion of NCAM140 
palmitoylation sites results in a shift of 
NCAM140-mediated signal transduction 
from FGF receptor–independent toward 
FGF receptor–dependent signaling. 
CHO cells were transfected with 
NCAM140 or NCAM140  and assayed 
for ERK1/2 activation by immunoblot 
analysis. (A) Immunoblot of NCAM140-
transfected CHO cell lysates analyzed 
for phosphorylated ERK1/2 (top). Bar 
graph shows ERK1/2 phosphorylation by 
densitometric analysis of immunoblots 
(bottom). Stimulation of NCAM140-
transfected CHO cells results in phos-
phorylation of ERK1/2, which is not at-
tenuated by the FGF receptor inhibitor 
PD173074, indicating an FGF receptor–
independent signaling of NCAM140. (B) 
Immunoblot of NCAM140 -transfected 
CHO cell lysates analyzed for phos-
phorylated ERK1/2 (top). Bar graph 
shows ERK1/2 phosphorylation revealed 
by densitometric analysis of immuno-
blots (bottom). Stimulation of 
NCAM140  also results in phosphorylation of ERK1/2, which in contrast to NCAM140 is impaired by PD173074. The bars show mean and 
SEM of 8–12 independent experiments. Asterisks denote statistical significance (paired t test) of attenuation of ERK1/2 phosphorylation due to 
treatment with the FGF receptor inhibitor compared with NCAM-mediated ERK1/2 activation in transfected CHO cells, which were not 
treated with PD173074 (***p   0.0005). IB, immunoblot for the molecules indicated. 
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(Fig. 5 B and Fig. 6 A) demonstrated that NCAM180-medi-
ated ERK1/2 phosphorylation was significantly attenuated
by the FGF receptor inhibitor (
 
 
 
50% reduction compared
with maximal activation), whereas NCAM140-mediated
signaling was not reduced. These data suggest that
NCAM180 uses the FGF receptor for signaling, whereas
NCAM140 does not act predominantly via this receptor.
 
Disruption of NCAM140 localization in lipid rafts 
attenuates FGF receptor–independent signaling
 
We next addressed the question whether the FGF receptor
independency of NCAM140 signaling is related to its pres-
ence in lipid rafts. Since NCAM140
 
 
 
 is excluded from lipid
 
rafts (Fig. 2 B, right, and Fig. 3 A), we first investigated
NCAM140
 
 
 
 signaling in CHO cells. Stimulation of
NCAM140
 
 
 
-expressing CHO cells with polyclonal NCAM
antibodies resulted in ERK1/2 phosphorylation levels com-
parable to those in NCAM140-transfected and -stimulated
cells (Fig. 6, A and B). However, in NCAM140
 
 
 
-trans-
fected CHO cells phosphorylation of ERK1/2 was signifi-
cantly attenuated by the FGF receptor inhibitor (
 
 
 
50% of
the maximal phosphorylation observed without FGF recep-
tor inhibitor), indicating a dependence of NCAM140
 
 
 
 sig-
naling on the FGF receptor.
The importance of lipid rafts for NCAM140 signaling
was further characterized by treatment of NCAM140-
expressing CHO cells with methyl-
 
 
 
-cyclodextrin (MCD)
that binds to cholesterol, thereby destroying the integrity of
lipid rafts. It has been reported that this treatment inhibits
signaling of receptor complexes that contain glycosyl phos-
phatidylinositol (GPI)-linked components (Bruckner et
al., 1999) but does not impair signaling of nonraft-associ-
ated receptors (Peiro et al., 2000). As shown in Fig. 7 A,
NCAM140-expressing CHO cells depleted of cholesterol
and stimulated with polyclonal NCAM antibodies were re-
duced in ERK1/2 phosphorylation by 
 
 
 
50% compared
with control cells, indicating an involvement of lipid rafts in
NCAM140 signaling.
 
Activation of 
 
t
 
he focal adhesion kinase
 
 
 
FAK by 
NCAM140 is impaired when NCAM140 is excluded 
from lipid rafts
 
The nonreceptor tyrosine kinase fyn and the focal adhesion
kinase FAK have been implicated in NCAM-mediated sig-
naling (Beggs et al., 1997) and NCAM-mediated neurite
outgrowth using dominant negative constructs of the two
kinases (Kolkova et al., 2000a). We reasoned that the FGF
receptor–independent signaling of NCAM140 could be
linked to raft-associated kinases, such as fyn, and phosphory-
lation of downstream effectors of fyn, namely FAK. Given
that FAK can activate the ERK1/2 pathway (Chen et al.,
1998) and that it plays a pivotal role in NCAM signaling
(Beggs et al., 1997), we investigated whether FAK phos-
phorylation is altered either when lipid rafts are disrupted by
MCD in NCAM140-transfected CHO cells or when the
NCAM molecule is excluded from lipid rafts by mutation of
palmitoylation sites (transfection with NCAM140
 
 
 
). Ty-
rosine-phosphorylated proteins were immunoprecipitated
from lysates of control or NCAM-stimulated cells trans-
fected with NCAM140 or NCAM140
 
 
 
. Immune com-
plexes were then subjected to immunoblot analysis with
FAK antibody. Up-regulation of FAK phosphorylation was
readily detectable after stimulation of NCAM140-trans-
fected CHO cells with polyclonal NCAM antibodies (Fig. 7
B). In contrast, only low levels of FAK immunoreactivity
could be detected in immunoprecipitates of NCAM140
 
 
 
-
transfected cells or in MCD-treated cholesterol-depleted
NCAM140-transfected cells. Furthermore, FAK activation
by NCAM140 was not reduced by the FGF receptor inhibi-
tor PD173074 (unpublished data). These observations pro-
vide evidence that NCAM140-mediated signaling via FAK
depends on the presence of NCAM140 in lipid rafts. Dis-
Figure 7. Lipid raft integrity is critical for NCAM140-mediated 
signal transduction. NCAM140-transfected CHO cells were treated 
with 10 mM MCD to disperse lipid rafts before NCAM stimulation 
with polyclonal antibodies. (A) Cholesterol-depleted cells ( MCD) 
display attenuated ERK1/2 activation in response to NCAM stimulation 
compared with control cells ( MCD). The bar graph (bottom) 
shows the mean and SEM of six independent experiments. Asterisks 
denote statistical significance (paired t test) of attenuation of ERK1/2 
phosphorylation in response to MCD treatment compared with 
antibody stimulation without MCD treatment (***p   0.0005). 
(B) NCAM140- and NCAM140 -transfected CHO cells were 
stimulated with polyclonal NCAM antibodies, and tyrosine-
phosphorylated proteins were immunoprecipitated (IP) from the cell 
lysates. Immunoblot analysis with a FAK protein antibody detects 
tyrosine-phosphorylated FAK in immunoprecipitates. NCAM140 
stimulation induces phosphorylation of FAK in control ( MCD) 
cells. Exclusion of NCAM140 from lipid rafts either by cholesterol 
depletion ( MCD) or by mutation of NCAM140 palmitoylation sites 
(NCAM140 ) attenuates phosphorylation of FAK. IB, immunoblot 
for the molecules indicated. 
NCAM cosignals via lipid rafts and the FGF receptor | Niethammer et al. 527
ruption of the integrity of the lipid raft matrix or exclusion
of NCAM140 from lipid rafts impairs the ability of
NCAM140 to activate the FAK kinase.
Among the three NCAM isoforms, only NCAM140 
can function as a neuritogenic receptor 
in hippocampal neurons
We then addressed the question whether lipid raft associa-
tion of NCAM is important for one of its biological func-
tions, such as promotion of neurite outgrowth. We trans-
fected cultured hippocampal neurons of NCAM-deficient
(NCAM
 / ) mice with one of the NCAM isoforms together
with the fluorescent marker enhanced green fluorescent pro-
tein (EGFP). This assay provides the advantage of reintro-
ducing the NCAM isoforms or the NCAM140  mutant
into their “natural” environment without NCAM back-
ground expression. The NCAM-transfected EGFP marked
neurons were stimulated with NCAM-Fc to induce neurite
outgrowth.
We first investigated which NCAM isoform would pro-
mote neurite outgrowth. Transfected neurons were stained
with polyclonal NCAM antibodies to ensure that all NCAM
isoforms and NCAM140  were expressed at the cell sur-
face at similar levels (Fig. 8 B). Quantification of neurite
length revealed that only NCAM140-transfected neurons
extended their neurites approximately twofold better upon
homophilic stimulation with NCAM-Fact than unstimu-
lated neurons, whereas stimulation of NCAM120- or
NCAM180-transfected neurons did not enhance neurite
outgrowth in comparison with cells transfected to express
only EGFP (Fig. 8 A). These observations indicate that only
NCAM140 can serve as a receptor for neuritogenesis,
whereas NCAM180 and NCAM120 are ineffective. It needs
to be mentioned that neurite length was also enhanced in
NCAM140-transfected cells in the absence of NCAM-Fc,
probably due to basal stimulation of NCAM140 by soluble
NCAM fragments known to be generated by proteolytic
processing of all NCAM isoforms (Probstmeier et al., 1989).
However, only NCAM140 can promote neurite outgrowth
upon homophilic triggering by NCAM fragments. The fact
that NCAM
 /  cells transfected with NCAM140 showed a
more pronounced neuritogenesis than wild-type neurons is
most likely due to the possibility that this isoform is the
most neuritogenic one of all three major isoforms and may
thus predominate over the neurite outgrowth signal trans-
Figure 8. Exclusion of NCAM140 from lipid rafts or inhibition of 
the FGF receptor completely inhibits NCAM140-mediated neurite 
outgrowth. (A) Cultured hippocampal neurons from NCAM-deficient 
mice (NCAM
 / ) were transfected with the indicated NCAM 
constructs and stimulated with NCAM-Fc. Means and SEM of the 
longest neurite are shown. Asterisks denote statistical significance 
of neuritogenesis after NCAM-Fc stimulation compared with 
unstimulated cultures (*p   0.05). (B) Confocal images of hippocampal 
neurons from NCAM
 /  mice transfected with the indicated NCAM 
isoform or EGFP and maintained in the presence (right) or absence 
(left) of NCAM-Fc. In case of EGFP transfection, the EGFP fluorescence 
signal is shown, whereas in case of transfection with the NCAM 
isoforms the cell surface immunoreactivity of NCAM is shown. 
Bar, 20  m. (C) Cultured hippocampal neurons from NCAM
 /  
mice were treated with the FGF receptor inhibitor and subsequently 
stimulated with NCAM-Fc. Inhibition of FGF receptor activity 
completely impairs NCAM-mediated neurite outgrowth. Means and 
SEM of the longest neurite are shown. Asterisks denote statistical 
significance of neuritogenesis after NCAM-Fc stimulation compared 
with unstimulated cultures (*p   0.01).528 The Journal of Cell Biology | Volume 157, Number 3, 2002
duction machinery in the absence of nonneuritogenic iso-
forms. Furthermore, the exclusive expression of the neurito-
genic NCAM140 isoform on the cell surface may also
account for the longer neurite length after NCAM-Fc stimu-
lation compared with wild-type neurons expressing all
NCAM isoforms endogenously (Fig. 8 C), since NCAM120
and NCAM180 are ineffective in promoting neurite out-
growth and might thus act as NCAM-Fc scavengers with re-
gard to neuritogenesis. Finally, it needs to be emphasized
that activation of the FGF receptor does not appear to be the
only prerequisite for NCAM-mediated neuritogenesis, since
NCAM180, which can also activate the FGF receptor (Fig.
5 B), is ineffective for neuritogenesis.
Exclusion from rafts or block of the FGF 
receptor diminishes the ability of NCAM140 
to promote neurite outgrowth
We then asked if NCAM140 facilitates cosignaling for effec-
tive neurite outgrowth by activating two distinct pathways:
the raft- and the FGF receptor–dependent pathway. We
blocked either of the two pathways and investigated the ca-
pability of NCAM140 to promote neurite outgrowth. First,
hippocampal neurons of NCAM
 /  mice were transfected
with NCAM140 , since it can activate the FGF receptor
but lacks the ability to activate raft-associated signaling cas-
cades, such as the fyn-FAK pathway. If our hypothesis is
valid, stimulation of NCAM140  should not promote neu-
ritogenesis. Indeed, NCAM140  did not promote neurite
outgrowth upon NCAM-Fc stimulation (Fig. 8 A) with
neurite lengths being in the same range as for NCAM120-,
NCAM180-, or only EGFP-transfected neurons.
Finally, we confirmed the influence of the FGF receptor in-
hibitor on NCAM-stimulated neuritogenesis (Fig. 8 C). For
this purpose, we stimulated hippocampal neurons with
NCAM-Fc in the presence of PD173074. NCAM-Fc induced
neurite outgrowth of hippocampal neurons in a reproducible
manner at concentrations used in previous publications (Meiri
et al., 1998). PD173074 blocked NCAM-dependent neurite
outgrowth completely. It is noteworthy that neuron survival
and neurite outgrowth was not influenced by PD173074 in the
absence of NCAM-Fc, since number of neurons and neurite
lengths maintained in the absence or presence of PD173074
were similar, underscoring the specificity of PD173074 for the
FGF receptor and supporting the importance of the FGF re-
ceptor for NCAM-mediated neuritogenesis.
Discussion
Two membrane subcompartments 
contain NCAM isoforms
In this study, we have shown that the three major isoforms
of NCAM are present in two membrane subcompartments.
One compartment comprises the Triton X-100–soluble
fraction containing the majority of membrane-associated
glycoproteins. The other compartment is the low density
Triton X-100–insoluble fraction of proteins, also named
lipid rafts or detergent resistant microdomains, which are
characterized by their accumulation of cholesterol and sphin-
golipids. Typically, this fraction is enriched in GPI-linked
glycoproteins, among them molecules of the immunoglobu-
lin superfamily such as F3–F11–contactin, TAG-1–axo-
nin-1, and Thy-1. Of the three major NCAM isoforms, the
GPI-linked NCAM120 was found to be highly enriched
in lipid rafts of neuroblastoma cells. This localization of
NCAM120 to rafts has also been reported previously for a
permanent oligodendrocyte cell line (Kramer et al., 1999).
The other two NCAM isoforms, NCAM140 and
NCAM180, were shown to be located both in the Triton
X-100–soluble and –insoluble compartments. From these
observations it seemed reasonable to assume that, as is the
case for some receptor molecules (Tansey et al., 2000), a
partitioning of NCAM isoforms into topologically distinct
compartments could contribute to a biologically meaningful
diversity of functions.
Selective localization of the different NCAM isoforms 
in membrane subcompartments contributes to distinct 
signal transduction pathways
In view of the idea that the FGF receptor mediates the com-
mon signal transduction pathway for all NCAM isoforms, it
appeared surprising at first sight that NCAM120 activates
ERK1/2 in an FGF receptor–independent way. It has been
demonstrated by us (this study) and others (Davy et al.,
2000) that the FGF receptor is absent in the low density Tri-
ton X-100–insoluble fraction where NCAM120 is enriched.
It is therefore unlikely that NCAM120 can “meet” the FGF
receptor for activation by a direct interaction. These results
are in line with previous observations showing that the intra-
cellular domain of NCAM140 is necessary to promote neu-
rite outgrowth (Saffell et al., 1995). Since several other sig-
nal molecules are enriched in lipid rafts, including members
of the src kinase family, heteromeric G-proteins, and the
neurite outgrowth-associated protein GAP-43 (Simons and
Ikonen, 1997; Arni et al., 1998; Aarts et al., 1999), it is
more likely that GPI-linked molecules, such as NCAM120
or F3–F11–contactin, cause productive interactions with
fyn by clustering in rafts, thereby activating ERK1/2 as has
been discussed elsewhere (Kramer et al., 1999; Crossin and
Krushel, 2000). Alternatively, activation of intracellular ki-
nases by GPI-anchored molecules may depend on cis inter-
actions with transmembrane molecules (Zeng et al., 1999).
NCAM180 is localized in both membrane subcom-
partments. However, NCAM180 signals predominantly
through the FGF receptor pathway as demonstrated by us-
ing the FGF receptor inhibitor. Although NCAM180 is lo-
calized in lipid rafts, it apparently lacks the ability to activate
FGF receptor–independent pathways, possibly due to the
additional 268 amino acids contributed by exon 18, which
are inserted into the intracellular domain of NCAM140.
Amino acids derived from exon 18 are particularly rich in
proline, and it is conceivable that these contribute in a yet
unknown manner to a particular conformation of the intra-
cellular domain of NCAM180 that prevents it from activa-
tion of the fyn-FAK kinase pathway (Beggs et al., 1997;
Kolkova et al., 2000b).
Like NCAM180, NCAM140 is localized in both membrane
subcompartments but in contrast to NCAM180 is able to acti-
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a classical fyn binding motif, it is conceivable that NCAM140
associates with other molecules in rafts that are able to signal
transduce. It is also possible that rafts can promote low affinity
“kiss-and-run” interactions due to locally enriched concentra-
tions of interacting molecules and thus serve as a matrix for the
orchestrated activation of signaling molecules. Beside its SH3
binding domain, fyn can undergo low affinity interactions via
its NH2 terminus as reported for the T cell receptor (Gauen
et al., 1994). Outside of lipid rafts NCAM140 triggers the
FGF receptor, which activates ERK1/2 and other pathways.
Whether NCAM140 interacts in this compartment in a tight
association with the FGF receptor as has been postulated
by Doherty, Walsh, and coworkers (Doherty et al., 1996;
Doherty and Walsh, 1996) and suggested by Cavallaro et al.
(2001) or whether it indirectly modulates the activity of the
FGF receptor (Kamiguchi and Lemmon, 2000) cannot be de-
termined by our present experiments.
Palmitoylation of NCAM140 is necessary for its 
localization in lipid rafts
Our data raise the question about the regulatory mecha-
nisms determining the localization of NCAM140 in the two
different compartments. We could show that ablation of the
four cysteine residues representing the palmitoylation sites
in the membrane proximal domain of NCAM140 reduces
its capacity to associate with lipid rafts. Replacement of cys-
teines by serines has been proven to be a useful tool to in-
hibit raft localization of proteins (Kabouridis et al., 1997;
Zhang et al., 1998). Abrogation of palmitoylation sites not
only destroys raft localization of NCAM140 but also reduces
the ability of NCAM140 to activate the fyn-FAK kinase
pathway, which was monitored by phosphorylation of FAK,
a direct downstream effector of fyn (Schlaepfer et al., 1994).
The view that raft association of NCAM140 is necessary for
activation of the fyn-FAK pathway is supported by the ob-
servation that destruction of lipid rafts by removal of choles-
terol with MDC reduces NCAM140-triggered activation of
the fyn-FAK kinase pathway. Our study underscores the im-
portance of NCAM140 recruitment to lipid rafts and dis-
closes the possibility that NCAM140 signaling can be regu-
lated by localization of NCAM140 in lipid rafts. The
mechanisms controlling enzymatic acylation of the cysteine
residues in NCAM are unknown presently but will be neces-
sary to study for the characterization of functional conse-
quences of NCAM140 accumulation in rafts. Also, the
mechanisms removing palmitoic acid from cysteine residues
to shift NCAM140 localization from lipid rafts to the non-
lipid raft compartment will need to be investigated.
Signaling pathways within the two membrane 
subcompartments need to be activated for
NCAM140-dependent neurite outgrowth
In our study, we blocked one of the two signal transduction
pathways, either by inhibition of the FGF receptor by
PD173074 or by preventing NCAM140 to accumulate in
lipid rafts. No residual neurite outgrowth promoting activity
could be seen either by blocking the initiation of the fyn-
FAK kinase pathway or by inhibiting activation of the FGF
receptor signaling pathway. Thus, NCAM140 has to be acti-
vated in both compartments in order to signal transduce ef-
fectively for induction of neurite outgrowth. It is not surpris-
ing that NCAM120 or NCAM180 are not neuritogenic
when transfected into NCAM-deficient neurons: NCAM120
localizes predominantly to lipid rafts and may thus not be
able to activate the FGF receptor even when present in the
same cell. Since NCAM120 is not highly expressed in neu-
rons, this scenario may not have biological relevance for neu-
rite outgrowth but may be important for signaling in glial
cells where NCAM120 is highly expressed. The observation
that NCAM180 does not activate the fyn-FAK kinase path-
way (Beggs et al., 1997) is in agreement with our experi-
ments, since NCAM180 does not mediate neurite outgrowth
when transfected into NCAM-deficient neurons.
However, our arguments should not imply that conver-
gence of the two pathways on ERK1/2, thereby enhancing
its activity by synergistic mechanisms and going beyond the
threshold necessary for effective neurite outgrowth, is the
only way of cosignaling. Other effectors signaling in the two
compartments that are not converging on the ERK1/2 path-
way may also achieve cosignaling and may thus be important
for neuritogenesis (hypothetical scheme can be seen in Fig.
9). Our observations also indicate that besides the FGF re-
ceptor there may be other yet unidentified receptors in-
volved in NCAM-mediated signaling, since activation of the
MAP kinase is not completely blocked by the FGF receptor
inhibitor when NCAM140  and NCAM180 are stimu-
lated. Nevertheless, our observations appear to reconcile two
divergent views on the activation of neurite outgrowth
through homophilic binding of NCAM: one favoring the
predominance of the fyn-FAK kinase pathway and the other
favoring a predominant action of the FGF receptor. Thus, a
biologically meaningful concept emerges in that an impor-
tant morphogenic event, such as neurite outgrowth, is not
controlled by only one signal transduction mechanism but
depends on the concomitant and coincident activation of at
least two signal transduction pathways for neuritogenesis.
Our results are in agreement with observations on a switch
in the palmitoylation of proteins early in the critical period,
which includes a decrease in the palmitoylation of GAP-43
and other major substrates characteristic of growth cones
(Patterson and Skene, 1999). Previous studies have also
shown that a similar reduction in palmitoylation of growth
cone proteins is sufficient to stop neurite extension, suggest-
ing that a developmental regulation of protein palmitoyla-
tion serves to down-regulate the molecular machinery for
neurite outgrowth (Hess et al., 1993; Patterson and Skene,
1994). It remains to be seen whether other physiological
functions that are regulated by recognition molecules, such
as neuronal survival, synaptogenesis, and synaptic plasticity,
also depend on their presence in lipid rafts and similar cosig-
naling mechanisms.
Materials and methods
DNA constructs
Rat NCAM140 and rat NCAM180/pcDNA3 were a gift of P. Maness (Uni-
versity of North Carolina, NC). Rat NCAM120 (a gift of E. Bock, University
of Copenhagen, Denmark) was subcloned into the pcDNA3 vector (Invi-
trogen). The plasmid coding for EGFP was from CLONTECH Laboratories,
Inc. The NCAM140  construct was generated as described previously (Lit-530 The Journal of Cell Biology | Volume 157, Number 3, 2002
tle et al., 1998) with the exception that mutations were performed using an
EcoRI-XhoI subfragment of NCAM140.
CHO and neuroblastoma cell culture, transfection of CHO cells, 
and NCAM or growth factor activation
Mouse neuroblastoma (Neuro2A) cells were maintained in DME contain-
ing 10% FCS and 1 mM sodium pyruvate. CHO were maintained in Glas-
gow modified Eagle’s medium (GMEM) containing 10% FCS. Cells were
transfected and stimulated as described in Online supplemental material.
Analysis of ERK1/2 and FAK phosphorylation
Cells were lysed in modified RIPA buffer consisting of 50 mM Tris, pH 7.6,
1% Triton X-100, 150 mM NaCl, 1 mM EDTA, 1 mM Na3VO4, 1 mM NaF,
and complete protease inhibitor cocktail (Roche Diagnostics) using 250  l
per well. Lysates were cleared by centrifugation at 12,000 g for 10 min at
4 C. After determination of protein concentration using the BCA protein
assay kit (Pierce Chemical Co.), small aliquots of supernatants were re-
moved and resuspended in 5  SDS buffer for SDS-PAGE and immunoblot
analysis with an antiphospho-p42/p44 ERK1/2 antibody (1:10,000; Sigma-
Aldrich). Blots were stripped and reprobed with an antibody against ERK1/2
protein (1:1,000, Santa Cruz Biotechnology, Inc.) to confirm equal protein
loading of samples. Phosphorylation of ERK1/2 was quantified by densito-
metric analysis of immunoblot phospho-ERK1/2 signals using Scion Image
(Scion Corporation). For analysis of phosphorylated FAK, tyrosine-phos-
phorylated proteins were immunoprecipitated from supernatants adjusted
to equal protein concentrations using agarose-coupled 4G10 antibodies
(Upstate Biotechnology). Agarose beads were resuspended in 50  l of 2 
SDS buffer and subjected to SDS-PAGE and immunoblot analysis using a
polyclonal antibody against FAK protein (Santa Cruz Biotechnology, Inc.).
Total protein levels were monitored by subjecting aliquots of the above su-
pernatants to SDS-PAGE followed by immunoblotting for FAK.
Isolation of detergent-resistant membrane fractions
Lipid rafts were isolated (Arni et al., 1998; Melkonian et al., 1999) with
slight modifications as described in Online supplemental material.
Cultures of hippocampal neurons
Cultures of hippocampal neurons were prepared by a combination of en-
zymatic and mechanical dissociation from 1- to 3-d-old age-matched
C57BL/6J or NCAM-deficient (NCAM
 / ) mice (Cremer et al., 1994) inbred
for at least nine generations onto the C57BL/6J background. During the
first 20 h after plating on a poly-L-lysine substrate, cells were maintained in
culture medium containing 10% specifically tested horse serum (Dityatev
et al., 2000). Afterwards, hormonally supplemented serum-free culture
medium containing Neurobasal-A medium, 2% B-27, 5  g/ml gentamycin
(all from Life Technologies), 0.5 mM L-glutamine, and 10 ng/ml  -FGF
(Sigma-Aldrich) was applied.
Calcium phosphate transfection of hippocampal neurons
Cells were transfected 24 h after seeding by the calcium phosphate
method (Ethell and Yamaguchi, 1999) using the Mammalian Transfection
Kit (Stratagene).
Treatment of hippocampal neurons with NCAM-Fc and FGF 
receptor inhibitor
Mouse NCAM-Fc (2.5  g/ml) (Chen et al., 1999) and/or the FGF receptor
inhibitor PD173074 (50 nM) were added to the cultures 28 h after seeding
the cells. 10 h after the first application of NCAM-Fc and PD173074, the
medium was replaced with the fresh medium containing the two com-
pounds and incubated for another 4 h before fixation of cells.
Detergent extraction of hippocampal neurons
Detergent extraction of hippocampal neurons was performed as described
by Ledesma et al. (1998).
Indirect immunocytochemistry and neurite
outgrowth measurement
Hippocampal neurons were fixed and stained with antibodies as previ-
ously described (Dityatev et al., 2000). For PIP2 (Laux et al., 2000) staining,
cells were permeabilized with 0.25% Triton X-100 in PBS and then
blocked with 3% BSA in PBS. Images of stained neurons were acquired us-
ing a confocal laser-scanning microscope (LSM510; ZEISS) with a thick-
ness of the optical slice of 5  m. Only neurites of isolated neurons were
traced, and their lengths were measured using Scion Image (Scion Corpo-
ration). Since the length of the longest neurites always correlated with
length of all neurites, only one parameter, namely the length of the longest
neurite, is documented in the figures. Immunofluorescence profiles were
calculated using LSM510 (ZEISS) software.
Fluorescence labeling of GM1
To visualize cholesterol-enriched lipid rafts, FITC-labeled cholera toxin B
subunit (Sigma-Aldrich) diluted in PBS containing 1% BSA to a final con-
centration of 8  g/ml was applied to fixed hippocampal neurons for 30
min at room temperature. GM1 immunofluorescence overlapping with
NCAM staining was quantified using Scion image (Scion Corporation).
Statistical analysis
Comparison of data was performed with the Student’s t test. Differences
were considered significant at p   0.05. Data are from at least three inde-
pendent experiments if not indicated otherwise.
Online supplemental material
Included in the supplemental materials are details of the lipid raft isolation
and images showing immunohistochemically the lipid raft association of
NCAM (Fig. S1) and Western blots showing the specificity of the FGF re-
ceptor inhibitor PD173074 (Fig. S2). Online supplemental materials are
available at http://www.jcb.org/cgi/content/full/jcb.200109059/DC1.
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Figure 9. Hypothetical diagram of NCAM140 cosignaling cascades. 
Within the plasma membrane, NCAM140 is located both in lipid 
rafts and outside of rafts, thus defining two membrane subcompart-
ments in which NCAM140 is present. The presence of NCAM140 in 
lipid rafts is regulated by palmitoylation of intracellular cysteines by 
yet unknown mechanisms. Upon homophilic activation, NCAM 
triggers distinct signal transduction pathways in the two compartments: 
in lipid rafts NCAM140 phosphorylates FAK most likely via raft-
associated fyn kinase, whereas in the nonraft compartment NCAM140 
facilitates FGF receptor–activated downstream signaling. Both 
pathways merge in the activation of ERK1/2 but can branch 
upstream of ERK1/2 into other pathways, such as the PLC  
activation or other yet unknown effectors. Activation of both pathways 
is necessary for NCAM140 to function as a neuritogenic receptor. 
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